VANTRELA ER FDA approval date

The FDA approved VANTRELA ER on 17 Jan 2017.

FDA approval date
17 Jan 2017

Drug identity has not yet been verified against registry records

Also recorded as HYDROCODONE BITARTRATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-01-17DayVANTRELA ERFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207975", "applicant_as_listed_by_fda": "TEVA BRANDED PHARM", "brand_names": ["VANTRELA ER"], "active_ingredients": ["HYDROCODONE BITARTRATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170117", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026